Thank you

This live web event has ended. Thank you for attending.

Description

PAH-CHD is the second most common form of associated PAH in adults. PAH-CHD subgroup data from Patent-1 study including change in 6MWD, WHO FC, PVR and NT-
pro-BNP data from baseline to week 12 will be presented.

This webinar is Sponsored by Bayer Healthcare.

By registering for this webinar, you agree your information will be shared with the sponsor.

No CME or MOC credits are available for this program.

Opinions expressed and resources shared may not have been reviewed by the ATS prior to distribution through ATS channels, or reflect official positions of the ATS, unless it is explicitly noted as a result of official ATS approval. References to specific commercial entities (companies) or products do not reflect review or endorsement by the ATS unless it is explicitly noted as a result of official ATS approval.